Military and NHS ready to roll out Covid-19 jab from next month, says Hancock
The new jab from Pfizer and its partner BioNTech was shown in early data to be more than 90% effective in preventing coronavirus infection.
The new jab from Pfizer and its partner BioNTech was shown in early data to be more than 90% effective in preventing coronavirus infection.
The announcement from Pfizer and its vaccine partner BioNTech was hailed by scientists as a significant breakthrough.
The words will be entered into CollinsDictionary.com and considered for future print editions.
Other public health measures will need to be in place to keep the virus under control.
There are more than 200 coronavirus vaccine candidates being tested around the world.
Pfizer said interim data showed its vaccine was more than 90% effective in preventing coronavirus infection.
Pfizer and BioNTech have announced promising results from their vaccine’s clinical trials.
The vaccine being developed by Pfizer and BioNTech has not yet received regulatory approval.
Scientists have welcomed the news but urged caution over the findings.
Pfizer and BioNTech published interim results showing their jab can prevent coronavirus.
Data suggests the vaccine created by Pfizer and BioNTech is 95% effective.
After successful trials, they could be rolled out at GP surgeries, pharmacies and mass testing centres.
The Falcons held on to secure the away win.
Professor Robin Shattock said trials of the vaccine are showing promising results.
But the researchers say some changes are occurring and these are useful to follow the spread of virus.